ABSTRACT. We determined metabolic responses after enteric galactose alimentation in 5-to 7-day-old newborn rats fasted for 24 h. The glycemic response was attenuated after enteric galactose feeding compared with the response after enteric glucose-fed rat pups. l4 C radioactivity in blood from galactose-fed pups was reduced as counts in blood galactose were lower than counts in blood glucose in glucose-fed pups. Nonetheless within 15 min, [I4 Cj from galactose appeared in blood glucose suggesting rapid conversion of galactose to glucose. The plasma insulin response was also attenuated after galactose feeding compared with the insulin response after enteric glucose. Hepatic glycogen content increased rapidly after enteric galactose feeding and was higher than after glucose feeding at 60, 120, and 180 min. Significant glycogen synthesis after oral glucose was delayed and occurred at 240 min. Carbon radioactivity in glycogen was higher in galactose fed pups between 15 and 360 min of the study. Serial determination of hepatic metabolites revealed an increase of galactose-1-phosphate levels after oral galactose at 240 and 300 min and a transient decline of ATP at 15 min. Other hepatic metabolites did not demonstrate significant differences between the two groups. These data suggest that hepatic glycogen synthesis is more rapid and occurs sooner after galactose than after glucose alimentation in previously fasted newborn rats. Galactose may enter a more direct pathway for neonatal hepatic glycogen synthesis. The relatively delayed entry of glucose label into hepatic glycogen and the delay of net glycogen synthesis after oral glucose suggest that glucose entry is not direct and may require further metabolism before incorporation into glycogen. Although galactose may replenish fasting neonatal hepatic glycogen content faster than glucose, there is concern over the elevated hepatic galactose-1-phosphate levels and the transient decline of ATP. (Pediatr Res 24: 302-307,1988) Abbreviations UDP-glucose, uridine diphosphate glucose PCA, perchloric acid Galactose is an important hexose source during the neonatal period. Galactose represents 50% of calories derived from carbohydrates among newborn mammals fed lactose-containing milk (I). In addition to serving as a substrate for oxidative metabolism and gluconeogenesis, galactose may also be a major
precursor for neonatal hepatic glycogen synthesis (2) (3) (4) (5) (6) . Previous investigations from our laboratory and other laboratories have demonstrated enhanced incorporation of galactose into glycogen when compared with glucose (2, 3, 6) . Additional investigations have demonstrated that hepatic galactose uptake exceeds that for glucose in vitro, whereas activation of hepatic glycogen synthase and inactivation of glycogen phosphorylase was greater in the presence of galactose than that for glucose (5, 6) . These data suggest that galactose or a metabolite of galactose may regulate the enzymes of hepatic glycogen synthesis. Alternately, the enhanced incorporation of galactose into glycogen relative to glucose may result from differences of the metabolic pathways of these two hexoses (3).
Our previous investigations of the metabolic differences between galactose and glucose studied glucose kinetics in addition to the metabolic pertubations in neonatal canine liver (7) . Hepatic metabolic alterations include an equivalent increase in glycogen content after the administration of glucose and galactose. However, radiolabeled carbon incorporation into glycogen from l4 C galactose was 10-fold more than that after l 4 C glucose (2) . In these investigations hepatic tissue sampling was delayed and occurred after completion of the kinetic studies. This delay was 3-4 h after the carbohydrate load (7) . Blood levels of galactose were maximum 30 min after ingestion and returned to very low baseline levels within 90 min. Because hepatic tissue was sampled 2-4 h after the peak of blood galactose levels, the immediate effects of hexose alimentation on hepatic glycogen synthesis may not be apparent. Delaying the sampling of tissue by this period of time may mask the perturbations of hepatic metabolism by galactose. Presently there is a paucity of investigations on the immediate effects of galactose on neonatal hepatic metabolism. The present study investigates the effects of enteric galactose alimentation on pertubations of hepatic metabolites from 15 to 360 min after hexose administration. The results suggest that galactose is rapidly incorporated into hepatic glycogen despite lower plasma insulin levels. Furthermore, glycogen synthesis from glucose was delayed and appeared to occur from an indirect pathway.
MATERIALS AND METHODS
Materials. D-[U-'~ Clglucose (SA 144 pCi/mmol), and D-[Ul 4 Clgalactose (SA 144 pCi/mmol) were purchased from New England Nuclear (Boston, MA). According to New England Nuclear specifics on this lot, the galactose was contaminated with less than 0.1 % glucose. After derivatization and chromatographic separation the actual contamination was equivalent to background counts. All enzymes were purchased from Sigma Chemical Co. (St. Louis, MO). Scintisol was purchased from Isolab Inc. (Akron, OH). Galactose (Sigma) and glucose (Mallinckrodt, St. Louis, MO) contained no detectable contamination with glucose or galactose, respectively. All chemicals and standards were analytical and reagent grade. Animals. This study was approved by the Case Western Reserve University Animal Welfare Committee. Pregnant Sprague Dawley rats with known dates of confinement were housed in cages and had free access to food and water in a light-dark cycled environment. Pregnant rats delivered spontaneously and the pups remained with the mothers in her cage for 4-6 days for nurturing, warmth, and general care. On day 4-6 the pups were removed from the mother's cage and placed in a warmed humidified incubator where they were fasted for 24 h.
Experimental design. Pups were weighed (7-12 g) and received an enteric feeding of 0.7 mglg of either [U-l4 Clgalactose, 0.25 &/g or [U-l4 Clglucose 0.25 pCi/g. The volume of this feed was 0.05 ml/g and was delivered by PE-50 tubing attached to a 1-ml spring. The tubing was placed carefully into the stomach of each rat without signs of gasping, cyanosis, or alterations of behavior after the feeding. Control or zero time rats were fed normal saline.
Pups were killed 15, 30, 60, 120, 180, 240, 300, and 360 min after enteric carbohydrate alimentation. Sample size varied from four to nine pups per each time point for each determination. Blood was sampled from the carotid vessels after decapitation whereas hepatic tissue was simultaneously and quickly (less than 5 s) freeze clamped to the temperature of liquid nitrogen between aluminum blocks. Blood and liver were then stored at -80" C.
Analyses. Circulating substrates. Blood was precipitated with 10% perchloric acid (PCA) and then neutralized with KzC03. Glucose was assayed as reported before (8) . Galactose was fluorometrically determined using galactose dehydrogenase (9) . Plasma insulin was assayed by double antibody radioimmunoassay (Amersham, Arlington Heights, IL). All analyses were run in duplicate and adapted to micromethods.
Hepatic determinations. Hepatic glycogen, [I4 C] label incor-
poration into glycogen and [I4 Clglucose-specific activity in glycogen were determined after homogenization of liver and subsequent alcohol precipitation at 0" C. Hepatic glycogen was further purified after two ether washes. Glycogen was then redissolved in distilled water and assayed enzymatically according to Vannucci and Duffy (10) . An aliquot of glycogen was then simultaneously counted on a @-scintillation counter to determined the [I4 C] content of the glycogen.
A second sample of hepatic tissue was pulverized to a fine powder at the temperature of dry ice, extracted with 3 M PCA and 10 mM EDTA, and then neutralized with K2C03. Standard fluorometric assays were used to determine hepatic, UDP-glucose, galactose-1-phosphate, fructose-6-phosphate, fructose 1, 6 diphosphate, phosphoenolpyruvate, pyruvate, lactate, citrate, and ATP (7, 9) . Galactose-1-phosphate was determined because elevated levels are associated with toxicity in galactosemia.
An additional sample of liver was homogenized at 0" C and assayed to determine glycogen synthase and phosphorylase activities according to Schwartz and Rall(1 I).
Glucose radioactivity. Neutralized samples of PCA-treated blood were evaporated to dryness and were then reconstituted with unlabeled water. Before placement of this neutralized sample on a Dowex AG 1-X8 column, galactose was completely converted to galactonate with galactose dehydrogenase (2) . After this derivatization step the sample was applied to the column. Glucose was first eluted in the water wash. Thereafter, galactonate was eluted with 0.02 N HCl. After glucose and the derivatized galactose were eluted, lactate and additional three carbon substrates were removed with 0.05 N HCl. This method completely separated glucose from galactose and three carbon substrates and resulted in more than 95% recovery of labeled compounds.
Radioactivity in l 4 C was counted by liquid scintillation for 10 rnin using external and internal standards. All counts were corrected for background, blanks, and quenching and were expressed as disintegrationslmin. Longitudinal changes across time are reported in the text and were analyzed with analyses of variance. On initial evaluation of the data we realized that most of the effects occurred sooner than 360 min, thus we concentrated the remaining experiments at earlier time points. When sufficient pups were studied at 360 min, we reported that data.
Statistical analyses.

RESULTS
Circulatingglucose, galactose, insulin, and radioactivity. Blood glucose increased markedly after enteric glucose alimentation and achieved peak values within 60 rnin of feeding (Fig. 1) . The glycemic response after an equivalent galactose feeding was markedly reduced as blood glucose levels increased but were significantly lower than blood glucose levels after enteric glucose administration at 15, 30, and 60 min of study. In both groups, blood glucose returned to fasting basal levels 300 min after enteric carbohydrate alimentation.
After galactose alimentation blood galactose levels increased from concentrations less than 0.1 to 3.7 mM within 15 rnin (Fig.  1 ). After this time blood galactose levels declined rapidly and achieved values comparable to glucose fed pups within 180 rnin of the study. There was no increment of blood galactose concentrations in glucose-fed pups.
Plasma insulin concentrations paralleled the glycemic responses noted in Figure 1 in both pup groups (Fig. 2 ). Plasma insulin levels achieved peak values between 30 and 60 min. Insulin concentrations were more after enteric glucose feeding than those for galactose-fed pups at 60 min. Insulin levels returned to basal fasting concentrations by 180 min of the study.
Within 15 rnin of l4 C glucose feeding radioactivity appeared in the blood (Fig. 3) . The amount of radioactivity in glucose increased and achieved peak values at 60 rnin of the study. The curve of radioactivity was similar to that for the actual glycemic response after glucose feeding as recorded in Figure 1 . Radioactivity appearing in blood galactose was also rapid and was equivalent to the total counts observed after glucose feeding at 15 rnin (Fig. 3) . Thereafter, counts in blood galactose declined slowly. The curve for appearance of l 4 C labeled galactose paralleled the curve for assayable galactose as noted in Figure 1 . l 4 C label appearing in blood glucose after l4 C galactose feeding was less than that in blood l4 C galactose at 15 rnin (Fig. 3) . After this time point, counts in blood galactose declined whereas the ap- pearance of counts from galactose into blood glucose increased and achieved peak levels at 60 min. Hepatic glycogen content and radioactivity. Hepatic glycogen levels were equivalent in both groups of pups 15 rnin after carbohydrate feeding and did not increase above baseline fasting concentrations at this time (Fig. 4) . After galactose alimentation hepatic glycogen content increased at 30 rnin and achieved peak values at 60 min. Hepatic glycogen content was greater after galactose than after glucose alimentation at 60, 120, and 180 rnin of the study as glycogen synthesis was delayed in glucosefed rats. After 240 min, glucose-fed pups demonstrated a marked increase of hepatic glycogen levels (Fig. 4) . At this time period blood glucose, plasma insulin, and l4 C-labeled glucose had already declined to fasting levels or levels that were within 20% of peak l4 C counts in blood.
BLOOD GLUCOSE FED GLUCME BLOOO GLUCOSE FED G U A C K S
After equivalent quantities of hexose, l4 C incorporation into hepatic glycogen from galactose exceeded that for l4 C incorporation after glucose at each time point studied (Fig. 5) . Galactose label appeared rapidly in glycogen (within 15 min) and did not achieve peak values until 120 to 300 rnin when an apparent plateau of incorporation into glycogen was noted (Fig. 5) . The curve for incorporation of l4 C label after galactose feeding paralleled the curve for total assayable glycogen synthesis after galactose alimentation (Fig. 4) .
In contrast to the results after galactose feeding, label incorporation into glycogen after glucose alimentation was attenuated, and increased slowly throughout the study period, achieving peak values between 240-300 min. The total counts incorporated into glycogen after glucose alimentation were 50% of the counts incorporated after galactose alimentation.
Hepatic metabolites and enzymes. To identify potential areas of hepatic regulation after enteric carbohydrate alimentation, key regulatory intermediates of carbohydrate metabolism were determined in newborn rats fed either glucose or galactose. Because galactose-1 -phosphate accumulation is associated with potential toxicity in galactosemia, this intermediate was also determined.
After glucose alimentation there were no statistical alterations of serial galactose-1-phosphate levels (Table 1) . In contrast, after galactose feeding galactose-1-phosphate levels increased compared with basal levels at 120 ( p < 0.05) and 240 ( p < 0.05) rnin (Table 1) . Compared with time-matched glucose-fed pups, galactose-fed pups had elevated galactose-1-phosphate concentrations at 30,240, and 300 min of the study.
Compared with fasted pups, hexose feeding resulted in a decline of hepatic UDP-glucose concentrations at 60 rnin ( p < 0.05) for glucose fed and at 60 and 180 rnin ( p < 0.05) for galactose-fed pups. There were no significant alterations between There were no significant changes for hepatic fructosed-phosphate or fructose-1, 6 diphosphate levels across time or between groups (data not presented). Phosphoenolpyruvate concentrations in contrast increased compared with fasting levels after hexose feedings at 60 and 180 min for glucose ( p < 0.05). Hepatic phosphoenolpyruvate was augmented in galactose-fed pups compared with glucose-fed pups 15 min after alimentation (Table 1) . In contrast, pyruvate concentrations became lower than fasting levels at 15 rnin ( p < 0.02) and 180 min ( p < 0.05) after glucose feeding. There were no significant differences for hepatic lactate or citrate levels (data not presented) as a function of time or enteric hexose. Hepatic ATP concentrations were not altered by glucose alimentation. In contrast, hepatic ATP levels were lower at 15 rnin in pups fed galactose compared with glucose-fed pups. This difference did not persist after 15 min (Table 1) . There were no differences in the total or percent activity of glycogen synthase in either hexose-fed groups. Glycogen synthase was 38 & 3.1 % in the active state during fasting and increased at 60 min to 72 & 5.5 and 74 + 6.1 % in glucose-and galactose-fed rats, respectively. Thereafter, glycogen synthase activation ranged between 72 and 88% without any time period demonstrating a difference of activation.
Glycogen phosphorylase was 100% in the active state during fasting and declined by 120 min to 81 f 8.8 and 85 + 7.2% in glucose and galactose alimented pups. There were no differences between pup groups after this time with values ranging from 7 1 to 9 1 % in the active state.
DISCUSSION
Glycogen metabolism.
Galactose has been demonstrated to be preferentially incorporated into hepatic glycogen compared with glucose in perinatal and adult mammals (2, 3, 6) . Previous investigations by this laboratory in newborn dogs have demonstrated a reduced rate of systemic glucose appearance after enteric galactose administration compared with glucose-fed newborn dogs (2, 3) . Given equivalent rates of absorption, these data suggested that there was augmented hepatic carbohydrate uptake when galactose was fed compared with glucose. Similar observations in the monkey fetus and adult rat have been noted by other investigators who demonstrated enhanced carbohydrate uptake with galactose as the hexose source in vitro (5, 6) . The enhanced carbohydrate uptake in the presence of galactose could be due to augmented hepatic glycogen synthesis or carbohydrate oxidation (4) . Previous studies in the newborn dog demonstrated enhanced incorporation of l 4 C label from galactose into glycogen or actual net glycogen synthesis after galactose alimentation compared with that for glucose (2, 3) . Nonetheless, the tissue in these studies was sampled 2-4 h after peak blood galactose concentrations, a time potentially far removed from maximal perturbations of tissue metabolites by galactose. Due to the prolonged time period between galactose feeding and tissue sampling, the immediate galactose-mediated effects on hepatic metabolism may be masked or hidden during the intervening unsampled time epochs.
In the present investigation we noted a dissociation between the effects of enteral galactose and glucose administration on hepatic glycogen synthesis in previously fasted newborn rats. This difference related to the rate of glycogen synthesis as galactose-fed rats demonstrated an immediate labeling of hepatic glycogen. This pattern could not be predicted from previous investigations of the effects of galactose on neonatal hepatic glycogen metabolism (2, 3, 7). Within 15 rnin after feeding, the appearance of counts incorporated into hepatic glycogen increased rapidly and eventually achieved values far in excess of that after labeled glucose feedings at every time point. Label incorporation into hepatic glycogen is probably a more sensitive method of assessing flux of a precursor into glycogen. However, the appearance of label itself into glycogen does not demonstrate net glycogen synthesis. Nonetheless, when the actual quantity of assayable hepatic glycogen was determined galactose-alimented pups demonstrated a much earlier increase in net glycogen synthesis compared with basal fasting levels and with rat pups fed an equivalent amount of glucose. Net glycogen content remained elevated after galactose alimentation for 240 additional min. This rapid rise of net glycogen synthesis and appearance of label into glycogen was initiated when blood galactose concentrations and blood galactose radioactivity were elevated.
In contrast to the pattern of hepatic glycogen synthesis after galactose alimentation, net glycogen content did not increase to the same magnitude as rapidly after enteric glucose feeding. Indeed the peak for net glycogen synthesis after enteric glucose was delayed and appeared 240 min into the study. Furthermore, in contrast to the marked appearance of label incorporated into glycogen after galactose, l4 C appearing in glycogen after glucose feeding was attenuated. Radioactivity incorporated in glycogen after glucose feeding increased much more slowly than after galactose feeding and achieved peak values between 240-300 min of the study. The pattern of net hepatic glycogen synthesis and label incorporation into glycogen after glucose feeding was out of phase with the peak glucose concentration that occurred at 60 min and the peak blood [I4 Clglucose radioactivity that also occurred at 60 min. Indeed net glycogen synthesis in glucosefed rats occurred after blood glucose levels and blood [I4 C] glucose counts had already declined. These data suggest that galactose is more readily incorporated into neonatal hepatic glycogen both as a function of rate of synthesis and as a function of the magnitude of net glycogen synthesis. It is also suggestive that galactose may be more rapidly incorporated into glycogen by way of a preferential or more direct metabolic pathway.
Glucose incorporation into glycogen in adult mammals may be indirect after being converted to three carbon compounds, thus requiring recycling through gluconeogenesis for glycogen synthesis. The latter has been proposed as the primary mechanism of net glycogen synthesis after glucose alimentation in adult mammals (1 2-17). Previous work by other laboratories has demonstrated that glucose is not necessarily converted directly to glycogen (1 2-17). Instead, glucose diverts gluconeogenic precursors away from hepatic glucose production toward hepatic glycogen synthesis (17) . Once converted to lactate, glucose carbons may then enrich the gluconeogenic precursor pool and function "indirectly" as a substrate for glycogen synthesis (12) . Preliminary data from our laboratory support this "indirect" mechanism for neonatal murine hepatic glycogen synthesis from glucose (1 8). In the present study, the delayed time sequence for neonatal glycogen synthesis after glucose feeding also suggests that glucose is not directly incorporated into glycogen, as compared with galactose. Furthermore, the marked and consistent reduction of labeled carbon incorporation into glycogen after glucose alimentation suggests that this label was diluted in a different and larger pool than was the label for galactose. The greater radioactivity in glycogen after galactose alimentation suggests that the "galactose" precursor pool is more closely linked to glycogen synthesis than is the "glucose" pool. The delayed appearance of labeled glucose into glycogen compared with the more rapid incorporation of galactose suggests that further metabolism of glucose, possibly to three carbon gluconeogenic precursors may occur before incorporation of glucose-derived carbons into glycogen. Previous work in adult rats had demonstrated that lactate may be the predominant precursor for hepatic glycogen synthesis after oral glucose feeding (19) . Indeed, the increase of lactate utilization could be accounted for by the increase of hepatic glycogen synthesis (19) . However, galactose may be directly diverted toward glycogen synthesis after phosphorylation and conversion to UDP-glucose and subsequent entry into the glycogen synthesis pathway. Although glycogen synthase appeared to be activated and phosphorylase to be less active after hexose administration there were no differences at any time points between the pup groups. Furthermore, plasma insulin levels were lower in galactose-fed pups. These data suggest that the activities of the enzymes of glycogen synthesis and the presence of insulin may only be permissive for neonatal hepatic glycogen synthesis (12, 13, 20) . The more important factor in neonatal glycogen synthesis from galactose or glucose may be the availability or specificity of the substrate rather than the presence of elevated plasma insulin levels or additional activation or inactivation of glycogen synthase or phosphorylase (2, 6) .
Hepatic intermediates. Previous studies in our laboratory have investigated the effects of enteric glucose and galactose alimentation on perturbations of hepatic glycolytic and Kreb cycle intermediates (7) . Compared with completely fasted newborn dogs, both glucose and galactose resulted in increased concentrations of various hepatic metabolites. Nonetheless we did not observe differences between hepatic metabolites in newborn dogs after glucose or galactose alimentation (7). These alterations were noted 2-4 h after enteric alimentation and thus may not reflect the acute alterations of metabolites at the time of enteric hexose feeding.
Presently there is a paucity of information on the metabolic effects of oral carbohydrate substrates on neonatal hepatic metabolism. In the present neonatal investigation the most striking and perhaps clinically significant observation was the increase of hepatic galactose-1-phosphate concentrations after galactose alimentation. Similar observations of an increase of fructose-lphosphate levels were noted in adult rats fed fructose (21) . Although the amount of galactose administered was a physiologic quantity, it may be concerning that galactose-1-phosphate levels increased after galactose alimentation and that this increment persisted after blood galactose levels had returned to normal. In contrast to newborn rats, hepatic galactose-1-phosphate levels were not elevated in newborn dogs 3-4 h after enteric galactose feeding. These data suggest that this response may be species related, but nonetheless, suggest that excessive galactose administration may result in accumulation of hepatic galactose-lphosphate and potentially produce adverse effects as noted in galactosemia (22) .
Another concerning but more transient alteration is the reduction of hepatic ATP concentrations noted 15 minutes after galactose administration. Similar observations have been reported after fructose feeding in adult rats (23) . In both studies glucose had no effect on ATP levels and the decline of ATP by both hexoses was transient. The reduction of ATP may result from rapid phosphorylation of galactose by galactokinase or a transient increase in adenine nucleotide deamination and probably has no clinical significance unless excessive quantities of galactose are administered (23, 24) .
A decline of hepatic UDP-glucose occurred in both glucoseand galactose-fed pups at times when glycogen synthesis was present and when glycogen synthase was in the more active state. Similar observations of reduced hepatic UDP-glucose levels and enhanced glycogen synthase activity were noted in adult rats fed glucose during glycogen synthesis (19) . With activation of glycogen synthase, substrates are "pulled" toward glycogen synthesis (20, 25) . The observed alterations of UDP-glucose are compatible with this sequence.
Glucosed-phosphate levels were elevated after both glucose and galactose feeding. The alteration of glucosed-phosphate suggests that both carbohydrates enriched this intermediate pool (19, 21) . Glucose would do this directly after phosphorylation by glucokinase (7) . Galactose was readily converted to glucose during these current experiments as evident by the rapid appearance of l4 C label from galactose into circulating glucose. This pathway must pass through the hepatic glucose-6-phosphate pool and could explain the elevated hepatic glucosed-phosphate concentrations in galactose-fed pups.
A consistent observation in both the present study and our previous work in newborn dogs after enteric hexose feeding has been an increase of hepatic phosphoenolpyruvate concentrations (7) . Similar observations have been noted in vitro and in vivo with the addition of glucose to cell cultures or after glucose feeding to starved adult rats (26.27) . Phosvhoenolv~ruvate levels . .
. often &crease during gluconeogenesis as pyruvate%nase activity is inhibited and Dvruvate carboxvlase activitv is stimulated (28) (29) (30) . Although wywould not exiect active i e t glu~oneo~enksis, recycling of lactate (as a precursor) during glycogen synthesis could explain in part the observed increased phosphoenolpyruvate concentrations and the reduced hepatic pyruvate levels. These latter observations are compatible with the indirect and delayed appearance of glucose-derived carbons in hepatic glycogen after recycling of lactate in the gluconeogenic pathway.
SUMMARY
Sequential determinants of hepatic metabolism after glucose and galactose administration demonstrated marked differences. Glycogen synthesis was augmented earlier after galactose feeding whereas glucose-induced glycogen synthesis was delayed. Glucose carbon radioactivity incorporation into glycogen was attenuated relative to galactose, suggesting dilution of glucose in another intermediary pool, possibly the lactate pool. Persistent elevations of hepatic galactose-1-phosphate levels and a transient decline of ATP concentrations after galactose alimentation may not be of clinical significance but raises important concerns for the clinical use of galactose as the sole carbohydrate source for newborn mammals.
